EVALUATION OF A BAYESIAN REGRESSION PROGRAM FOR PREDICTING WARFARIN RESPONSE

被引：14

作者：

BOYLE, DA

LUDDEN, TM

CARTER, BL

BECKER, AJ

TAYLOR, JW

机构：

[1] UNIV TEXAS, HLTH SCI CTR, DEPT PHARMACOL, 7703 FLOYD CURL DR, SAN ANTONIO, TX 78284 USA

[2] SK&F LABS, DIV DRUG METAB, KING OF PRUSSIA, PA USA

[3] UNIV TEXAS, COLL PHARM, AUSTIN, TX 78712 USA

[4] UNIV HOUSTON, COLL PHARM, HOUSTON, TX 77004 USA

[5] MED CTR HOSP VERMONT, COLL PHARM, BURLINGTON, VT 05401 USA

[6] UNIV MISSISSIPPI, MED CTR, JACKSON, MS 39216 USA

来源：

THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 03期

关键词：

D O I：

10.1097/00007691-198905000-00010

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：276 / 284

页数：9

共 29 条

[1] INVESTIGATION OF PATIENTS WITH ABNORMAL RESPONSE TO WARFARIN [J].

BENTLEY, DP ;

BACKHOUSE, G ;

HUTCHINGS, A ;

HADDON, RL ;

SPRAGG, B ;

ROUTLEDGE, PA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (01) :37-41

[2] A NOTE ON THE GENERATION OF RANDOM NORMAL DEVIATES [J].

BOX, GEP ;

MULLER, ME .

ANNALS OF MATHEMATICAL STATISTICS, 1958, 29 (02) :610-611

[3]

CARTER BL, 1987, CLIN PHARMACY, V6, P37

[4] PREDICTION OF MAINTENANCE WARFARIN DOSAGE FROM INITIAL PATIENT RESPONSE [J].

CARTER, BL ;

REINDERS, TP ;

HAMILTON, RA .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (01) :23-26

[5]

GORDON BM, 1984, CLIN PHARMACY, V3, P297

[6]

HANSTEN PD, 1985, DRUG INTERACTIONS

[7] CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN - UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP [J].

HOLFORD, NHG .

CLINICAL PHARMACOKINETICS, 1986, 11 (06) :483-504

[8]

HOLLANDER M, 1973, NONPARAMETRIC STATIS

[9]

LEE C, 1987, CLIN PHARMACY, V6, P406

[10]

MCGHEE JR, 1981, J AM OSTEOPATH ASSOC, V80, P335

← 1 2 3 →